These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31571881)

  • 1. Comparative diagnostic accuracy of ACE-III and MoCA for detecting mild cognitive impairment.
    Wang BR; Zheng HF; Xu C; Sun Y; Zhang YD; Shi JQ
    Neuropsychiatr Dis Treat; 2019; 15():2647-2653. PubMed ID: 31571881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation Study of the Chinese Version of Addenbrooke's Cognitive Examination III for Diagnosing Mild Cognitive Impairment and Mild Dementia.
    Li X; Yang L; Yin J; Yu N; Ye F
    J Clin Neurol; 2019 Jul; 15(3):313-320. PubMed ID: 31286702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Chinese version of Addenbrooke's cognitive examination III for detecting mild cognitive impairment.
    Pan FF; Wang Y; Huang L; Huang Y; Guo QH
    Aging Ment Health; 2022 Feb; 26(2):384-391. PubMed ID: 33533261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic utility of the Addenbrooke's Cognitive Examination - III (ACE-III), Mini-ACE, Mini-Mental State Examination, Montreal Cognitive Assessment, and Hasegawa Dementia Scale-Revised for detecting mild cognitive impairment and dementia.
    Senda M; Terada S; Takenoshita S; Hayashi S; Yabe M; Imai N; Horiuchi M; Yamada N
    Psychogeriatrics; 2020 Mar; 20(2):156-162. PubMed ID: 31448862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a modified Chinese version of Mini-Addenbrooke's Cognitive Examination for detecting mild cognitive impairment.
    Pan FF; Cui L; Li QJ; Guo QH
    Brain Behav; 2022 Jan; 12(1):e2418. PubMed ID: 34843170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Diagnostic Accuracy of Five Cognitive Screening Tests for Diagnosing Mild Cognitive Impairment in Patients Consulting for Memory Loss.
    Valles-Salgado M; Matias-Guiu JA; Delgado-Álvarez A; Delgado-Alonso C; Gil-Moreno MJ; Valiente-Gordillo E; López-Carbonero JI; Fernández-Romero L; Peña-DeDiego L; Oliver-Mas S; Matías-Guiu J; Diez-Cirarda M
    J Clin Med; 2024 Aug; 13(16):. PubMed ID: 39200837
    [No Abstract]   [Full Text] [Related]  

  • 7. A Validation Study of the Chinese Version of the Mini-Addenbrooke's Cognitive Examination for Screening Mild Cognitive Impairment and Mild Dementia.
    Yang L; Li X; Yin J; Yu N; Liu J; Ye F
    J Geriatr Psychiatry Neurol; 2019 Jul; 32(4):205-210. PubMed ID: 30987514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Malay Version of Addenbrooke's Cognitive Examination III in Detecting Mild Cognitive Impairment and Dementia.
    Kan KC; Subramaniam P; Shahrizaila N; Kamaruzzaman SB; Razali R; Ghazali SE
    Dement Geriatr Cogn Dis Extra; 2019; 9(1):66-76. PubMed ID: 31043965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Diagnostic Accuracy of the ACE-III, MIS, MMSE, MoCA, and RUDAS for Screening of Alzheimer Disease.
    Matías-Guiu JA; Valles-Salgado M; Rognoni T; Hamre-Gil F; Moreno-Ramos T; Matías-Guiu J
    Dement Geriatr Cogn Disord; 2017; 43(5-6):237-246. PubMed ID: 28384640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Mini-Addenbrooke's Cognitive Examination in Mild Cognitive Impairment in Arabic Speakers.
    Qassem T; Khater MS; Emara T; Rasheedy D; Tawfik HM; Mohammedin AS; Tolba MF; Aly El-Gabry D; Abdel Aziz K; Saber HG
    Dement Geriatr Cogn Disord; 2021; 50(2):178-182. PubMed ID: 34293741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Addenbrooke's Cognitive Examination-III in Mild Cognitive Impairment in Arabic Speakers in Egypt.
    Qassem T; Khater MS; Emara T; Rasheedy D; Tawfik HM; Mohammedin AS; Tolba MF; Saber HG; Aly El-Gabry D; Abdel Aziz K
    Dement Geriatr Cogn Disord; 2020; 49(4):418-422. PubMed ID: 33080612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Portuguese version of Addenbrooke's Cognitive Examination III in mild cognitive impairment and dementia.
    Peixoto B; Machado M; Rocha P; Macedo C; Machado A; Baeta É; Gonçalves G; Pimentel P; Lopes E; Monteiro L
    Adv Clin Exp Med; 2018 Jun; 27(6):781-786. PubMed ID: 29790690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MoCA, ACE-R, and MMSE versus the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Neuropsychological Battery after TIA and stroke.
    Pendlebury ST; Mariz J; Bull L; Mehta Z; Rothwell PM
    Stroke; 2012 Feb; 43(2):464-9. PubMed ID: 22156700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Chinese version of Addenbrooke's Cognitive Examination III for diagnosing dementia.
    Wang BR; Ou Z; Gu XH; Wei CS; Xu J; Shi JQ
    Int J Geriatr Psychiatry; 2017 Dec; 32(12):e173-e179. PubMed ID: 28170114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of Chinese Versions of Addenbrooke's Cognitive Examination: A Narrative Review.
    Cao LX; Wang G; Guo QH; Zhang W; Bak T; Huang Y
    Healthcare (Basel); 2022 Oct; 10(10):. PubMed ID: 36292500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis.
    Ciesielska N; Sokołowski R; Mazur E; Podhorecka M; Polak-Szabela A; Kędziora-Kornatowska K
    Psychiatr Pol; 2016 Oct; 50(5):1039-1052. PubMed ID: 27992895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of Addenbrooke's cognitive examination III for detecting mild cognitive impairment and dementia in Japan.
    Takenoshita S; Terada S; Yoshida H; Yamaguchi M; Yabe M; Imai N; Horiuchi M; Miki T; Yokota O; Yamada N
    BMC Geriatr; 2019 Apr; 19(1):123. PubMed ID: 31035933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of Chinese version of ACE-Ⅲ in type 2 diabetes mellitus patients with mild cognitive impairment].
    Xin JW; Xiao XL; Chen XC; Pan XD
    Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(44):3455-3459. PubMed ID: 29275578
    [No Abstract]   [Full Text] [Related]  

  • 19. Validation of the Cuban Version of Addenbrooke's Cognitive Examination-Revised for Screening Mild Cognitive Impairment.
    Broche-Pérez Y; López-Pujol HA
    Dement Geriatr Cogn Disord; 2017; 44(5-6):320-327. PubMed ID: 29393151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Beijing version of the Montreal Cognitive Assessment as a brief screening tool for mild cognitive impairment: a community-based study.
    Yu J; Li J; Huang X
    BMC Psychiatry; 2012 Sep; 12():156. PubMed ID: 23009126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.